Search

everythinglearnresearchcommunity

for

Search:↓

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Dermatologists are the main innovators in noninvasive cosmetic procedures, with other specialties also contributing significantly.

Tailored scar treatments are needed for different body areas to improve appearance and function.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Hair analysis shows infants and mothers in north-western Spain are exposed to environmental pollutants, with factors like diet and residence affecting pollutant levels.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Severe acne in a young girl may indicate underlying hormonal issues.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The UK published guidelines recommending that only qualified medical professionals should perform cosmetic procedures, with the possibility of these guidelines influencing future laws.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Robotic systems in cosmetic surgery are promising but need more development and research.